title: Acute severe ulcerative colitis: Changing treatment paradigms.
authors.affiliation: Harry Perkins Institute of Medical Research, School of Medicine and Pharmacology, University of Western Australia, Murdoch, Western Australia, Australia; Centre for Inflammatory Bowel Diseases, Saint John of God Hospital, Subiaco, Western Australia, Australia.
authors.forename: Ian C
authors.initials: IC
authors.lastname: Lawrance
mesh_terms: D000208:Acute Disease; D000894:Anti-Inflammatory Agents, Non-Steroidal; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D018680:Cholinergic Antagonists; D016360:Clostridioides difficile; D003015:Clostridium Infections; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy* / Q000821:virology; D000075202:Contraindications; D003524:Cyclosporins / Q000627:therapeutic use; D003586:Cytomegalovirus Infections; D013505:Digestive System Surgical Procedures; D004750:Enteral Nutrition; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab / Q000627:therapeutic use; D009294:Narcotics; D012720:Severity of Illness Index; D020246:Venous Thrombosis / Q000517:prevention & control
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D015415:Biomarkers; D018680:Cholinergic Antagonists; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D009294:Narcotics; D002097:C-Reactive Protein; D000069285:Infliximab